Sherbrooke Park Advisers’s Hims & Hers Health HIMS Stock Holding History

Sherbrooke Park Advisers’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,281	Closed	-$297K	–	744
2024 Q4	$297K	Buy	12,281 +2,054	+20%	+$50.9K	0.09%	405
2024 Q3	$188K	Buy	+10,227	New	+$183K	0.04%	767
2023 Q4	–	Sell	-44,285	Closed	-$279K	–	563
2023 Q3	$279K	Buy	+44,285	New	+$329K	0.09%	342

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Sherbrooke Park Advisers's HIMS Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 12,281 shares — an estimated $297K sold.

Sherbrooke Park Advisers first reported a position in HIMS in Q3 2023 and held it in 3 quarters. The position peaked at $297K in Q4 2024. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

Sherbrooke Park Advisers reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 12,281 Hims & Hers Health shares in Q1 2025, an estimated $297K.
Sherbrooke Park Advisers first reported a position in Hims & Hers Health in Q3 2023 and held it in 3 quarters.
Sherbrooke Park Advisers's Hims & Hers Health position peaked at $297K in Q4 2024.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.